XML 118 R102.htm IDEA: XBRL DOCUMENT
v3.25.4

Note 18 - Share Incentive Plans - Summary of Restricted Stock Units (Details) - Restricted Stock Units (RSUs) [Member] | 12 Months Ended
--- | ---
Dec. 31, 2025 $ / shares shares
Equity instruments outstanding (in shares) | 158,919
Awards Granted 20220314 [Member] |
Number of instruments granted (in shares) | 50,004
Equity instruments outstanding (in shares) | 16,905
Fair value as of grant date (in dollars per share) | $ / shares | $ 30.46
Remaining lives (Year) | 1 year
Awards Granted 20220429 [Member] |
Number of instruments granted (in shares) | 4,522
Equity instruments outstanding (in shares) | 1,263
Fair value as of grant date (in dollars per share) | $ / shares | $ 31.39
Remaining lives (Year) | 1 year
Awards Granted 20230505 [Member] |
Number of instruments granted (in shares) | 130,873
Equity instruments outstanding (in shares) | 29,007
Fair value as of grant date (in dollars per share) | $ / shares | $ 22.25
Remaining lives (Year) | 3 months
Awards Granted 20240301 [Member] |
Number of instruments granted (in shares) | 105,257
Equity instruments outstanding (in shares) | 47,418
Fair value as of grant date (in dollars per share) | $ / shares | $ 26.52
Remaining lives (Year) | 1 year 3 months
Awards Granted 20240401 [Member] |
Number of instruments granted (in shares) | 5,495
Equity instruments outstanding (in shares) | 3,627
Fair value as of grant date (in dollars per share) | $ / shares | $ 29.12
Remaining lives (Year) | 1 year 3 months
Awards Granted 20250303 [Member] |
Number of instruments granted (in shares) | 36,843
Equity instruments outstanding (in shares) | 35,973
Fair value as of grant date (in dollars per share) | $ / shares | $ 70.34
Remaining lives (Year) | 2 years 3 months
Awards Granted 20250305 [Member] |
Number of instruments granted (in shares) | 14,921
Equity instruments outstanding (in shares) | 14,921
Fair value as of grant date (in dollars per share) | $ / shares | $ 67.02
Remaining lives (Year) | 3 months
Awards Granted 20250508 [Member] |
Number of instruments granted (in shares) | 8,464
Equity instruments outstanding (in shares) | 8,464
Fair value as of grant date (in dollars per share) | $ / shares | $ 75.66
Remaining lives (Year) | 6 months
Awards Granted 20250714 [Member] |
Number of instruments granted (in shares) | 1,341
Equity instruments outstanding (in shares) | 1,341
Fair value as of grant date (in dollars per share) | $ / shares | $ 74.61
Remaining lives (Year) | 2 years 8 months 8 days

X
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(01) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(01) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (e)(1) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=tpb_AwardsGranted20220314Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=tpb_AwardsGranted20220429Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=tpb_AwardsGranted20230505Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=tpb_AwardsGranted20240301Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=tpb_AwardsGranted20240401Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=tpb_AwardsGranted20250303Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=tpb_AwardsGranted20250305Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=tpb_AwardsGranted20250508Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=tpb_AwardsGranted20250714Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |